Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05LXP
|
|||
Former ID |
DNC012319
|
|||
Drug Name |
7,12-Dihydro-7,12-diaza-indeno[1,2-a]fluorene
|
|||
Synonyms |
5,12-Dihydroindolo[3,2-a]carbazole; 111296-91-4; 5,12-dihydroindolo[3,2-c]carbazole; Indolo[3,2-]arbazole, 5,12-ihydro-; Indolo[3,2-a]carbazole, 5,12-dihydro-; 5H,12H-Indolo[3,2-a]carbazole; AC1NFSZ0; SCHEMBL224017; CHEMBL53230; DTXSID80405771; QQWXDAWSMPLECU-UHFFFAOYSA-N; MolPort-027-835-190; ZINC13490703; 2059AA; AKOS016009131; 5,12-dihydro-indolo[3,2-a]carbazole; Indolo[3,2-a]carbazole,5,12-dihydro-; SC-48298; AJ-63955; AX8227529
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H12N2
|
|||
Canonical SMILES |
C1=CC=C2C(=C1)C3=C(N2)C4=C(C=C3)NC5=CC=CC=C54
|
|||
InChI |
1S/C18H12N2/c1-3-7-14-11(5-1)12-9-10-16-17(18(12)20-14)13-6-2-4-8-15(13)19-16/h1-10,19-20H
|
|||
InChIKey |
QQWXDAWSMPLECU-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 111296-91-4
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | GABA(A) receptor alpha-1 (GABRA1) | Target Info | Inhibitor | [1] |
Gamma-aminobutyric acid receptor (GAR) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Retrograde endocannabinoid signaling | ||||
GABAergic synapse | ||||
Morphine addiction | ||||
Nicotine addiction | ||||
Reactome | Ligand-gated ion channel transport | |||
GABA A receptor activation | ||||
WikiPathways | SIDS Susceptibility Pathways | |||
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | ||||
Iron uptake and transport |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis of novel 3-substituted beta-carbolines as benzodiazepine receptor ligands: probing the benzodiazepine receptor pharmacophore. J Med Chem. 1988 Sep;31(9):1854-61. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.